欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/1900/001
药品名称Hidroclorotiazida + Amilorida Aurovitas
活性成分
    • amiloride chloride 2.84 mg
    • hydrochlorothiazide 25.0 mg
剂型Tablet
上市许可持有人Aurovitas Unipessoal, Lda.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Netherlands (NL)
许可日期2021/04/28
最近更新日期2022/05/07
药物ATC编码
    • C03EA01 hydrochlorothiazide and potassium-sparing agents
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase